Kairos Pharma Statistics
NYSE: KAPAHealthcareBiotechnologyUSD
0.9595+0.0895 (+10.29%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Kairos Pharma by the numbers
Kairos Pharma has a market capitalization of $3.2 million based on 3.39M shares outstanding. With trailing EPS of $-2.16, Kairos Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 48.9% below its 50-day average and 72.1% below its 200-day average.
Average daily trading volume is 602.89K shares, or about $578,469 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KAPA valuation vs. peer median
| Metric | KAPA | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.25M | $3.33M | -3% |
| Avg. volume | 602.89K | 111.02K | +443% |
Peer median across 8 companies: APVO, CVKD, MBIO, CMND, XRTX, SLXN, REVB, SXTP.
Valuation
- Market cap
- $3.25M
- EPS (TTM)
- $-2.16
- Shares outstanding
- 3.39M
Price and trading
- Previous close
- 0.87
- Open
- 0.93
- Day range
- 0.92 – 1.24
- 52-week range
- 0.848 – 9.24
- Beta
- —
- Volume
- 5.77M
- Average volume
- 602.89K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 3.25M
- Forward Pe
- -0.20
- Eps
- -2.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.24
- Week52 Low
- 0.85
- Avg Volume
- 602.89K
- Shares Outstanding
- 3.39M
- Ma50
- 1.88
- Ma200
- 3.44
- Pct From52w High
- -89.62%
- Pct From52w Low
- 13.15%